BASF Calls Off Bid for Evonik
BASF has announced that it will end its efforts to acquire Evonik Industries AG, a producer of specialty and fine chemicals. The decision follows Evonik’s rejection of two non-binding all-cash offers previously made by BASF.
BASF first confirmed in a September 25, 2026, press statement that it was in exploratory talks to acquire Evonik and later specified in a statement made on November 19, 2026, that it was not prepared to increase its latest all-cash offer of 24 euros ($26) per share.
“Despite the indication that BASF was prepared to consider a further moderate increase to its offer, the Executive Board of Evonik has not shown meaningful engagement until today [as reported on November 19, 2026],” said BASF in a statement on November 19, 2026. “At the same time, BASF’s assessment of Evonik’s standalone prospects and associated risks did not provide sufficient grounds to justify a higher valuation. Against this background, BASF does not consider it to be in the best interests of its shareholders to pursue the transaction at a higher price.”
BASF is one of the largest chemical companies in the world, with 108,251 employees worldwide and 234 production sites in 93 countries worldwide (as reported for end-of-year 2025). Its sales reached approximately EUR 59.7 billion ($68 billion) in 2025.
Evonik generated EUR 14.1 billion ($16.1 billion) in sales in 2025. In June (June 2026), the company announced further restructuring in addition to its previously announced Evonik Tailor Made restructuring and efficiency program originally announced in 2023. The June announcement specified that a total of 3,200 jobs will be eliminated, including 2,150 positions in Germany. This measure will run from 2027 to the end of 2029. In late September (September 2026), the company announced details of its growth strategy over the next three years.
In commenting on ending its efforts to acquire Evonik, Dr. Markus Kamieth, Chairman of the Board of Executive Directors of BASF, said in its November 19, 2026, press statement: “We are convinced that BASF’s derisked all-cash offer of 24 euros per share would have represented significant additional value for Evonik shareholders. We continue to believe that the combination would create a more powerful chemical company under BASF’s ownership, generating additional value for shareholders as well as benefits for employees and customers of the combined entity.”
The company further said in its statement: “BASF has always said that acquisitions are a ‘could do’ not a ‘must do’ to strengthen and grow its core businesses. By ending its efforts to take over Evonik, the company underlines its commitment to disciplined capital allocation and attractive shareholder distributions.”
Source: BASF

